DV
Dividend Vision

AARD — Aardvark Therapeutics, Inc.

Aardvark Therapeutics, Inc. (AARD)

Total return is -54.3% over the past 1.5 years, 83.8 points behind SPY at 29.5%. Its deepest 1-year drawdown was 80.0%.

AARD is a healthcare equity stock with an inception date of February 13, 2025. The fund lacks publicly available data on its distribution frequency, yield profile, and expense ratio at this time. Given its recent launch and equity focus within the healthcare sector, additional information may become available as the fund establishes its operational history.

AARD key facts

Asset type
Stock
Asset class
Equity
Inception date
02/13/2025
Distribution frequency
None
Last close
$6.54
Market cap
$143,126,896
Average volume
69100.0
Payout ratio
0.0
Forward P/E
0.0
EPS
$-3.31